MTOR and head and neck cancer: Moreover, paeoniflorigenone-inhibiting PI3K/AKT/mTOR/p70S6K signaling leads to a suppression of necroptosis by inactivating necroptotic proteins (RIP and MLKL) in head and neck cancer cells [386].